Skip to main content
Download PDF

Metabolic syndrome among people living with HIV on antiretroviral therapy in Mwanza, Tanzania

BMC Endocrine Disorders volume 23, Article number: 88 (2023) Cite this article

Abstract

Background

HIV and antiretroviral drugs, particularly protease inhibitors and nucleoside reverse transcriptase inhibitors, may increase the risk of Metabolic Syndrome (MetS) among people living with HIV (PLHIV). However, following the introduction of better drugs like dolutegravir, data on the burden of MetS are limited. This study aimed to assess the prevalence of MetS and associated factors among PLHIV on antiretroviral therapy (ART) in Tanzania.

Methods

This was a cross-sectional study among PLHIV aged ≥ 18 years on antiretroviral therapy for ≥ 1 year at Bugando Medical Centre in Mwanza conducted in 2020. Demographic and healthy-lifestyle-related non-communicable disease risk factors data were collected. Additionally, data on lipid profile, blood glucose, blood pressure, and waist circumference were collected for analysis of MetS according to the International Diabetes Federation criteria. Factors associated with MetS were assessed using logistic regression. A P ≤ 0.05 was considered statistically significant.

Results

Data for 223 participants were analyzed. The mean (SD) age was 44 (± 12) years and 79.8% (178) were females. A majority 78% (174) were on a tenofovir, lamivudine,and dolutegravir regimen. About 12.1% (27) were either current or past smokers, 45.3% (101) were past alcohol drinkers, 22.9% (51) were current drinkers, 12.1% (27) reported taking ≥ 5 servings of vegetables and fruits per day and 5.8% (13) were physically inactive. The prevalence of MetS was 22.9%. The only factors that were associated with Mets were fat mass index and adequate intake of vegetables and fruits, (adjusted odds ratio (aOR) 2.9, 95% CI 1.0, 7.9, P = 0.04) and (aOR1.2, 95% CI 1.0, 1.3, P = 0.02), respectively).

Conclusion

The prevalence of MetS remains high among PLHIV. Adiposity and adequate fruit and vegetable intake increased the risk. The introduction of new ART regimens shows no effect on MetS prevalence. Research is needed to understand how lifestyle changes could reduce MetS in PLHIV.

Peer Review reports

Background

UNAIDS reports that HIV-related mortality decreased between 2010 and 2020 due to the widespread use of antiretroviral therapy (ART) [1]. The decrease is due to ART effects on viral load suppression, body immunity improvement as well a reduction in the incidence of opportunistic infections [2]. Despite these beneficial effects, there is evidence that ART may increase the risk of non-communicable disease (NCD) co-morbidities [3,4,5,6,7]. Studies have shown that ART regimens, particularly those containing protease inhibitors (PIs) and nucleoside reverse transcriptase inhibitors (tNRTIs) [6, 8] could lead to HIV-associated lipodystrophy, dyslipidemia,and insulin resistance, thus increasing the risk of metabolic syndrome (MetS) [9]. MetS, previously described by Reaven as syndrome X, is a collection of closely related cardiovascular risk factors, including hypertension, insulin resistance, obesity, and dyslipidemia, with abdominal obesity and insulin resistance being the core manifestation [10,11,12]. MetS is associated with an increased risk of diabetes mellitus and cardiovascular diseases than its components [13]. Therefore, diagnosing MetS early could help prioritize interventions to reduce the risk of these cardio-metabolic diseases and improve the long-term health of people living with HIV (PLHIV) [13].

Although the use of PIs and tNRTIs is phasing out in sub-Saharan Africa [14], it is still important to explore the burden of MetS and its associated factors. There is limited literature on the burden of MetS in the era of newer and better ART drugs such as dolutegravir. The available evidence is contradicting, with some studies showing improvement of metabolic syndrome with dolutegravir-based regimens [15] while others showing an increased risk of weight gain [16, 17] and hyperglycemia [18]. Against this background, this study aimed to explore the current prevalence of MetS among PLHIV on ART, as well as factors associated with increased risk of MetS in this population.

Methods

Study design and setting

This was a cross-sectional study conducted from June to August 2020 among adults PLHIV on ART for ≥ 1 year attending Bugando Medical Centre (BMC) HIV clinic in Mwanza, northwestern Tanzania. BMC is the zonal hospital for the Lake Victoria Zone in northwest Tanzania, serving a population of approximately 15 million. The HIV prevalence in the Lake Zone is 6.5%, higher than the national average of 4.9% [19]. At the time of the study, Bugando HIV clinic had more than 15,000 HIV-infected patients enrolled with over 5700 on ART [20].

Sample size and sampling

Based on a previous studyconducted in Mwanza in 2016, the prevalence of MetS among PLHIV was 21.7% [21]. To estimate the prevalence in the current study with a precision of 5% and 80% power we needed to recruit a minimum of 261 patients.Using Microsoft excel random sampling function, participants were randomly selected out of 5700 patients who were in care at BMC during the time of recruitment and had been on ART for ≥ 1 year. Participants were contacted by phone and introduced to the study and those not reachable were excluded. Information on study objectives, procedures including a requirement to have an overnight fast for at least 8 h, risks, and benefits were communicated to potential participants before consenting. If an individual agreed to participate in the study, an appointment was scheduled for them to attend the research clinic based on their availability, between 08:00 h to 10:00 h to minimize the possibility of breaking the fast before enrollment. Upon arrival, participants were re-introduced to the study and consented. Those who gave their written consent were enrolled in the study.

Data collection and measurements

Using structured interviews, information on demography, education level, employment, religion, and marital status were collected. Data on possession of assets (residential house, electric or gas cooker, bicycle, motorcycle, car, sewing machine, radio, television, air-conditioning, mobile phone, animals, chicken, boat, and any rented property), source of water for domestic use and type of toilet used were collected and used to compute socioeconomic status using principal component analysis (PCA) [22], which was then grouped in tertiles (i.e. lower, middle and upper). The World Health Organization (WHO) Global Physical Activity Questionnaire (GPAQ) was used to collect reported data on the level of physical activity [23]. Total physical activity was computed to metabolic equivalents of tasks (MET) in minutes per week and categorized as an adequate level if MET was ≥ 600 as recommended by WHO [24]. Smoking status was elicited and grouped as never smoked and ever smoked (including past smokers (who quit smoking for > 1 year) and current smokers (smoking in the past year)). Alcohol consumption was grouped as never consumed, past consumption (quit intake for > 1 year), and current consumption (consuming within the past 1 year). Fruits and vegetables intake was assessed based on consumption history in the past 7 days. To facilitate data collection, we prepared a list of commonly available fruits and vegetables in Mwanza and provided a container for participants to estimate the portion of fruits and vegetables they were taking on days they reported to be taking fruits or/and vegetables. Using this information, a trained research assistant converted the quantities ingested into servings; with one serving weighing approximately 80 g. Based on WHO recommendations, we regarded an intake of ≥ 5 servings per day as being adequate [25]. ART cards were used to obtain information on ART regimens and HIV treatment duration.

Anthropometric measurements were assessed by trained research assistants using standardized methods [26]. Bodyweight was determined to the nearest 0.1 kg using a digital scale (Seca, Germany) and height was measured to the nearest 0.1 cm using a stadiometer fixed to the clinic wall (Seca, Germany). Waist and hip circumferences were measured using non-stretchable tape (to 1 mm). All measurements were taken in triplicate and means were used during the analysis. Waist circumference was used to assess abdominal obesity which is one of the International Diabetes Federation (IDF) MetS criteria; where waist circumference of ≥ 80 cm for females and ≥ 94 cm for males were defined as abdominal obesity [27]. Participants underwent bioelectrical impedance analysis (BIA) to estimate fat mass (kg) using a body composition analyzer (Tanita BC418, Tokyo, Japan). To adjust for height, the fat mass index (FMI) was computed as fat mass (kg) divided by height2 (m).

Blood pressure was measured using a standardized protocol. Participants were asked to rest for at least 5 min, and then three serial measurements of BP were taken one minute apart, using a digital blood pressure monitor sphygmomanometer (CH-432B, Citizen Systems Japan Co Ltd) with subjects in the sitting position. Having an average systolic blood pressure of ≥ 130 mmHg and/or average diastolic blood pressure of ≥ 85 mmHg was included in the index defining MetS [28].

Fasting venous blood samples were recollected and used for the analysis of total serum cholesterol, high-density lipoproteins (HDL), low-density lipoproteins (LDL), and triglycerides using a chemistry analyzer (ERBA XL, S.R.O Mannheim, Germany). Total cholesterol > 5.2 mmol/l, triglycerides > 1.7mmol/l, and HDL < 1.03 mmol/l in males and < 1.29 mmol/l in females and LDL > 3.3mmol/l were considered impaired. HDL and triglycerides results were used in the index defining MetS [27]. Participants were contacted one day before the clinic visit and instructed to come fasting. Upon arrival and before glucose testing, participants were asked if they had fasted for at least 8 h before visiting the clinic. Those on fast were requested to provide venous blood for fasting blood glucose (FBG) analysis using a Hemocue machine (Hemocue 201 RT, Hemocue AB, Angelholm, Sweden). FBG 6.1 to 7.0 mmol/l was impaired fasting glucose while FBG > 7.0 mmol/l was diabetes.

MetS definition

MetS was the main outcome measured and was defined as the presence of central obesity plus any two of the following: triglycerides ≥ 1.7 mmol/l or specific treatment for this lipid abnormality, HDL < 1.03 mmol/l in males and < 1.29 mmol/l in females or specific treatment for this lipid abnormality, elevated blood pressure (systolic blood pressure ≥ 130 mmHg and/or diastolic blood pressure ≥ 85mmHg) or treatment of previously diagnosed hypertension, and fasting hyperglycemia (fasting blood glucose ≥ 7.0 mmol/l) or previously diagnosed type 2 diabetes as recommended by IDF [27]. The following were the criteria in this study; MetS1: Presence of abdominal obesity, elevated serum triglyceride, and decreased serum HDL levels. MetS2: Presence of abdominal obesity, elevated serum triglyceride, and systolic blood pressure equal or more than 130 mmHg and/or diastolic blood pressure equal or more than 85 mmHg. MetS3: Presence of abdominal obesity, elevated serum triglyceride, and fasting blood glucose more than or equal to 7 mmol/L. MetS4: Presence of abdominal obesity, decreased serum HDL level, and fasting blood glucose more than or equal to 7 mmol/L. MetS5: Presence of abdominal obesity, decreased serum HDL level, and systolic blood pressure equal or more than 130 mmHg and/or Diastolic blood pressure equal or more than 85 mmHg. MetS6:Presence of abdominal obesity, systolic blood pressure equal to or more than 130 mmHg and/or diastolic blood pressure equal to or more than 85 mmHg and fasting blood glucose more than or equal to 7 mmol/L. MetS: Any of the 1–6 criteria [27].

Data management and statistics

Data were entered into CSPro and analyzed in STATA version 16. Histograms and the Shapiro-Wilk test were used to assess the distribution of continuous variables. Background characteristics of the study participants are presented as medians and interquartile ranges or means and standard deviations (SDs), or percentages of categorical variables. Associations between Mets and predictor variables (age, sex, education level, marital status, employment status, smoking status, alcohol drinking, physical activity, fruit, and vegetable intake, and FMI tertiles) were investigated using logistic regression. Univariable logistic regression was conducted for all predictor variables and those whose effect sizes were significant at P < 0.1 were included in multiple logistic regressions. The odds ratio (OR) was presented with 95% CI and P < 0.05 indicated significant differences.

Results

A total of 261 participants were recruited, but only 85.4% (223) had complete outcome data and were included in the analysis. The mean age of included participants was 44 (± 12) years and 79.8% (178) were females (Table 1). Among these participants, 12.1% [27] were either current or past smokers, 45.3% (101) were past alcohol drinkers, 22.9% (51) were current drinkers and only 12.1% [27] reported taking ≥ 5 servings of vegetables and fruits per day (Table 1).

Table 1 Background characteristics of the study participants
Full size table

Fig. 1 summarizes the proportions of each of the MetS traits of the study participants. Over two-thirds of the study participants had central obesity, 8.5% [19] had elevated serum triglycerides, 18.8% [42] had diabetes, 26% (58) had hypertension and 60.1% (134) had lowHDL cholesterol.

Fig. 1
figure 1

Distribution of metabolic syndrome traits among study participants [27]

Full size image

Of all IDF MetS criteria, the combination of abdominal obesity, low HDL levels, and hypertension accounted for the largest proportion compared to other combinations. The overall prevalence of MetS was 22.9% (51) (Supplementary Fig. 1).

Table 2 summarizes univariable and multivariable logistic regression analysis for the factors associated with MetS. In a multivariable model, we found that increased fat mass index and intake of adequate vegetable and fruit (≥ 5 servings per day) were associated with higher odds of having MetS ((aOR 1.2, 95% CI: 1.0, 1.3, P = 0.01) and (aOR 2.9, 95% CI: 1.0, 1.3, P = 0.04), respectively). In addition, we found that participants aged ≥ 45 years had higher odds of having MetS (OR 4.5 95% CI 2.2, 9.0, P = 0.001), although this was not significant in the multivariable model (aOR 2.3 95% CI 0.9, 5.9, P = 0.1). ART regimens and time since HIV diagnosis were not predictors.

Table 2 Univariable and multivariable logistic regression analysis of the factors associated with metabolic syndrome
Full size table

Discussion

The current study found the prevalence of MetS among HIV patients on ART to be 22.9%. In addition, adiposity seemed to increase the risk of MetS and we found that adequate intake of vegetables and fruits was associated with a higher burden of MetS. We also found MetS burden seemed to be higher in people aged ≥ 45 years.

The prevalence of MetS observed in this study is higher than the reported global prevalence of MetS by IDF (18%) [29]. This is similar to the previously reported prevalence in Tanzania and other countries in sub-Saharan Africa. For instance, a study conducted in urban and rural settings in Tanzania in 2015, reported a prevalence of 25.6% [30]. Another study done in the same setting as the current study between 2012 and 2013 reported a 21.3% prevalence of MetS in PLHIV on ARTs [21]. A study done in Kenya in 2016 reported a prevalence of 19.2% [31]. The similarity of proportions in the current and previous studies suggests that the change in first-line ART regimens has little to do with the MetS since the high prevalence is still observed despite changes in ART regimens and no associations have been observed between MetS and different regimens. The high prevalence of MetS is likely to be attributed to other factors including consumption of unhealthy diets, although we found a high intake of vegetables and fruits were associated with a higher rather than lower burden of MetS.

The finding that a higher intake of vegetables and fruits was not beneficial is contrary to other studies which suggest that consumption of vegetables and fruits may reduce MetS risk [32]. However, the findings of this study are similar to a recently published study in the same setting which reported that adequate intake of vegetables and fruits was associated with a higher burden of prediabetes and diabetes, although the findings did not achieve statistical significance [33]. These findings were not expected but could be due to the high glycemic index of common fruits eaten in Mwanza, such as watermelons, which in some cases maybe comparable to that of some carbohydrate-rich foods like white bread [34]. Indeed, a recent 20-year-long prospective cohort study from the Stockholm Diabetes Prevention Program, involving 6961 participants, reported an increased risk for prediabetes and diabetes among men and women with higher intakes of bananas and tomatoes [35]. The high intake of glucose could result in toxicity of β-cells leading to high fasting glucose and MetS [36, 37]. Alternatively, high glucose intake could result in central obesity leading to a higher risk of MetS. However, the latter is unlikely to be the major mechanism since the observed association between vegetables and fruit intake with MetS was independent of adiposity.

Irrespective of our observations, we suggest that education on a healthy diet with the correct amount of vegetables and fruits with low glycemic indices, as well as other non-vegetable foods, might have a positive health effect in reducing MetS [38]. Further studies are warranted to understand how lifestyle changes could help reduce the MetS burden among PLHIV in Tanzania.

In the currency analysis, we analyzed fat mass index rather than body mass index (BMI) as a measure of adiposity because BMI includes both lean and fat mass and may attenuate the effect of adiposity on MetS. In this report, we found that, in a multivariable model, people in the upper tertile of the fat mass index had an increased risk of MetS. This is because increased body fat increases the risk of central obesity, insulin resistance, hyperglycemia, diabetes mellitus, atherogenesis, and the development of hypertension [39] which are the building blocks for MetS. Thus, incorporating body fat measurements in HIV clinics would early identify people at high risk of MetS and institute lifestyle interventions to reduce the risk of MetS and other non-communicable diseases.

The risk of MetS in the older age group has been observed to be high, these findings were expected and they are in line with the literature. Increased age has been documented to increase the risk of all MetS traits including fasting hyperglycemia, hypertension, and lipid abnormalities [40, 41]. Aging decreases the ability of pancreatic β-cells to manufacture and secrete insulin and increases the risk of diabetes [41], reduced vascular distensibility, and increases the risk of hypertension. Furthermore, aging increases adipose tissues dysfunction, increases the risk of lipid abnormalities, and increases the risk of cardiovascular disease [41, 42]. These findings suggest the need to prioritize interventions for the aging population to reduce their MetS and other non-communicable diseases risk.

Strengths and limitations

The current study is among the few studies that have explored the prevalence of MetS in PLHIV. The study included PLHIV who are on old and new ART regimens making it possible to assess if new ART drugs might change the burden of MetS and thus making it easier to generalize the findings in the wider HIV population. However, the study had several limitations. It was a cross-sectional study so causal associations cannot be confirmed. Also, the switching of the older ARTs to dolutegravir a few years before this study may explain the lack of association that has been observed. Information on the ART duration was missing in a majority of participants. Only 35% had date of ART initiation recorded in their current ART card, proper recording of all information in ART cards should be emphasized. Physical activity data collected was reported rather than observed and the study may have been susceptible to social desirability bias although we validated instruments used in data collection.

Conclusions and recommendations

This study concludes that, compared to the global prevalence of MetS, the prevalence of MetS in PLHIV is still high in Tanzania despite transitioning to newer and better ART regimens. We suggest routine identification of people with MetS to enhance the interventions done at treatment and care HIV clinics. We also found fat mass was associated with elevated MetS risk, fat mass screening would therefore benefit PLHIV, we suggest that this measurement should be included in HIV care to identify at-risk populations for early interventions and reduce the risk of MetS to improve long-term health among PLHIV.Using tools that were pre-tested and validated in other studies [33], we found adequate intake of vegetables and fruits increases MetS burden. This calls for longitudinal studies in PLHIV to re-examine the effect of vegetable/fruits intake in MetS in Tanzania.

Data Availability

The data set used during the current study is available from the corresponding authors upon reasonable request.

Abbreviations

HIV:

Human immunodeficiency virus

PLHIV:

People living with HIV

MetS:

Metabolic syndrome

ART:

Antiretroviral therapy

NCD:

Non-communicable diseases PI:Protease inhibitors

NRTI:

Nucleoside reverse transcriptase inhibitors

MET:

Metabolic equivalents of tasks

LDL:

Low-density lipoprotein

HDL:

High-density lipoprotein

FMI:

Fat mass index

IDF:

International diabetes federation

WHO:

World health organization

References

  1. UNAIDS. UNAIDS Data 2021. 2021.

  2. Dye AC, Williams BG, Title. Antiretroviral therapy is the principal cause of tuberculosis decline in southern and eastern Africa. 2018.

  3. Tiozzo E, Konefal J, Adwan S, Martinez LA, Villabona J, Lopez J, et al. A cross-sectional assessment of metabolic syndrome in HIV-infected people of low socio-economic status receiving antiretroviral therapy. Diabetol Metabolic Syndrome. 2015;7:1–8.

    Article  CAS  Google Scholar 

  4. Msoka TF, Guilder GPV, Smulders YM, Furth MV, Bartlett JA, Agtmael MAV. Association of HIV-infection, antiretroviral treatment and metabolic syndrome with large artery stiffness : a cross-sectional study. 2019:1–8.

  5. Husain NE, Noor SK, Elmadhoun WM, Almobarak AO, Awadalla H, Woodward CL et al. Diabetes, metabolic syndrome and dyslipidemia in people living with HIV in Africa: Re-emerging challenges not to be forgotten. HIV/AIDS - Research and Palliative Care. 2017;9:193–202.

  6. Nzuza S, Zondi S, Hurchund R. Highly active antiretroviral Therapy-Associated Metabolic Syndrome and Lipodystrophy. Pathophysiology and Current Therapeutic Interventions. 2017;7:103–16.

    CAS  Google Scholar 

  7. Palios J, Kadoglou NPE, Lampropoulos S. The pathophysiology of HIV-/HAART-related metabolic syndrome leading to cardiovascular disorders: The emerging role of adipokines.Experimental Diabetes Research. 2012;2012.

  8. Innes S, Abdullah KL, Haubrich R, Cotton MF, Browne SH. High prevalence of dyslipidemia and insulin resistance in HIV-infected prepubertal african children on antiretroviral therapy. Pediatr Infect Disease J. 2016;35:e1–e7.

    Article  Google Scholar 

  9. Bune GT, Yalew AW, Kumie A. The extents of metabolic syndrome among antiretroviral therapy exposed and ART naive adult HIV patients in the Gedeo-zone, Southern-Ethiopia: a comparative cross-sectional study. Arch Public Health. 2020;78:40.

    Article  PubMed  PubMed Central  Google Scholar 

  10. Reaven GM, Banting. lecture 1988. Role of insulin resistance in human disease Diabetes 1988;37(12):1595 – 607.

  11. Eva Kassi PP. Gregory Kaltsas and George Chrousos. Metabolic Syndrome: Definitions and Controversies.BMC Medicine. 2011;9(48).

  12. Huang PL. A comprehensive definition for metabolic syndrome. Dis Model Mech. 2009;2(5–6):231–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Moller SP, Amare H, Christensen DL, Yilma D, Abdissa A, Friis H, et al. HIV and metabolic syndrome in an ethiopian population. Ann Hum Biol. 2020;47(5):457–64.

    Article  PubMed  Google Scholar 

  14. Tanzania TURo. National Guidelines for the Management of HIV And AIDS. 2019.

  15. Zala RQJRLM-CC. Comparative changes of lipid levels in Treatment-Naive, HIV-1-Infected adults treated with Dolutegravir vs. Efavirenz, Raltegravir, and Ritonavir-Boosted darunavir-based regimens over 48 weeks. Clin Drug Investig. 2015;35:211.

    Article  PubMed  PubMed Central  Google Scholar 

  16. Eifa BA, Ketema W. Could a Dolutegravir-Based antiretroviral therapy lead to clinical obesity? A retrospective cohort study conducted at Hawassa University Comprehensive Specialized Hospital in Hawassa, Sidama, Ethiopia. AIDS Res Treat. 2022;2022:2965325.

    PubMed  PubMed Central  Google Scholar 

  17. Sterling TR, Koethe JR, Raffanti SP, Hulgan T, Castilho JL, Turner M, et al. Greater Weight Gain in treatment-naive persons starting Dolutegravir-based antiretroviral therapy. Clin Infect Dis. 2020;70(7):1267–74.

    Article  PubMed  Google Scholar 

  18. Hirigo AT, Gutema S, Eifa A, Ketema W. Experience of dolutegravir-based antiretroviral treatment and risks of diabetes mellitus. SAGE Open Medical Case Reports. 2022;10:2050313X210794.

    Article  Google Scholar 

  19. Tanzania Commission for AIDS (TACAIDS) ZACZ. Tanzania HIV Impact Survey (THIS) 2016–2017: final report. Dar es Salaam, Tanzania.;; December 2018.

  20. Haule A, Msemwa B, Mgaya E, Masikini P, Kalluvya S. Prevalence of syphilis, neurosyphilis and associated factors in a cross-sectional analysis of HIV infected patients attending Bugando Medical Centre, Mwanza, Tanzania. BMC Public Health. 2020;20(1):1862.

    Article  PubMed  PubMed Central  Google Scholar 

  21. Kingery JR, Alfred Y, Smart LR, Nash E, Todd J, Naguib MR, et al. Short-term and long-term cardiovascular risk, metabolic syndrome and HIV in Tanzania. Heart. 2016;102:1200–5.

    Article  PubMed  Google Scholar 

  22. Filmer D, Pritchett LH. Estimating wealth effects without expenditure data—or tears: an application to educational enrollments in states of india. Demography. 2001;38(1):115–32.

    CAS  PubMed  Google Scholar 

  23. Claire L, Cleland RF, Hunter F, Kee ME, Cupples, Sallis JF, Tully aMA. Validity of the Global Physical Activity Questionnaire (GPAQ) in assessing levels and change in moderate-vigorous physical activity and sedentary behaviour.BMC Public Health. 2014.

  24. Chu AH, Ng SH, Koh D, Muller-Riemenschneider F. Reliability and validity of the self- and interviewer-administered versions of the global physical activity questionnaire (GPAQ). PLoS ONE. 2015;10(9):e0136944.

    Article  PubMed  PubMed Central  Google Scholar 

  25. WHO/FAO. Fruit and Vegetables for Health: Report of a Joint FAO/WHO Workshop,1–3 September 2004, Kobe, Japan. 2004.

  26. Rockville M. National Health and nutrition examinatory survey III (NHANES) Body Measurements (Anthropometry) Westat, Inc.; 1988. Report No.: 978-1499243628.

  27. IDF. The IDF consensus worldwide definition of the metabolic syndrome. 2006.

  28. Zhu L, Spence C, Yang JW, Ma GX. The IDF Definition Is Better Suited for Screening Metabolic Syndrome and Estimating Risks of Diabetes in Asian American Adults: Evidence from NHANES 2011–2016.J Clin Med. 2020;9(12).

  29. Nguyen KA, Peer N, Mills EJ, Kengne AP. A meta-analysis of the metabolic syndrome prevalence in the global HIV-infected population. PLoS ONE. 2016;11:1–27.

    Google Scholar 

  30. Kagaruki G, Kimaro G, Mweya C, Kilale A, Mrisho R, Shao A, et al. Prevalence and risk factors of metabolic syndrome among individuals living with HIV and receiving antiretroviral treatment in Tanzania. Br J Med Med Res. 2015;5(10):1317–27.

    Article  Google Scholar 

  31. Kiama CN, Wamicwe JN, Oyugi EO, Obonyo MO, Mungai JG, Roka ZG, et al. Prevalence and factors associated with metabolic syndrome in an urban population of adults living with HIV in Nairobi, Kenya. Pan Afr Med J. 2018;29:90.

    Article  PubMed  PubMed Central  Google Scholar 

  32. Lee M, Lim M, Kim J. Fruit and vegetable consumption and the metabolic syndrome: a systematic review and dose-response meta-analysis. Br J Nutr. 2019;122(7):723–33.

    Article  CAS  PubMed  Google Scholar 

  33. Jeremiah K, Filteau S, Faurholt-Jepsen D, Kitilya B, Kavishe BB, Krogh-Madsen R, et al. Diabetes prevalence by HbA1c and oral glucose tolerance test among HIV-infected and uninfected Tanzanian adults. PLoS ONE. 2020;15(4):e0230723.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  34. Fiona S, Atkinson KF-P, Jennie C, Brand-Miller. International tables of Glycemic Index and Glycemic load values: 2008. Diabetes Care. 2008;31:2281–3.

    Article  Google Scholar 

  35. Barouti AA, Tynelius P, Lager A, Bjorklund A. Fruit and vegetable intake and risk of prediabetes and type 2 diabetes: results from a 20-year long prospective cohort study in swedish men and women. Eur J Nutr. 2022;61(6):3175–87.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  36. Li Z, Wang D, Ruiz-Narvaez EA, Peterson KE, Campos H, Baylin A. Starchy Vegetables and Metabolic Syndrome in Costa Rica.Nutrients. 2021;13(5).

  37. Chen Z, Watanabe RM, Stram DO, Buchanan TA, Xiang AH. High calorie intake is associated with worsening insulin resistance and beta-cell function in hispanic women after gestational diabetes mellitus. Diabetes Care. 2014;37(12):3294–300.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  38. Verschuren WMM, Boer JMA, Temme EHM. Optimal diet for cardiovascular and planetary health.Heart. 2021.

  39. He H, Pan L, Du J, Jin Y, Wang L, Jia P, et al. Effect of fat mass index, fat free mass index and body mass index on childhood blood pressure: a cross-sectional study in south China. Transl Pediatr. 2021;10(3):541–51.

    Article  PubMed  PubMed Central  Google Scholar 

  40. Kavishe B, Biraro S, Baisley K, Vanobberghen F, Kapiga S, Munderi P, et al. High prevalence of hypertension and of risk factors for non-communicable diseases (NCDs): a population based cross-sectional survey of NCDS and HIV infection in Northwestern Tanzania and Southern Uganda. BMC Med. 2015;13:1–21.

    Article  Google Scholar 

  41. Chia CW, Egan JM, Ferrucci L. Age-related changes in glucose metabolism, hyperglycemia, and Cardiovascular Risk. Circ Res. 2018;123(7):886–904.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  42. Alemayehu AmberbirI VB, Singano V, Matengeni A, Pfaff C, Ismail Z, Allain TJ, ChanI AK, Sumeet K, Sodhi, Joep J, van Oosterhout. Effect of cardio-metabolic risk factors on all-cause mortality among HIV patients on antiretroviral therapy in Malawi: a prospective cohort study. PLoS ONE. 2019;14:e0210629.

    Article  Google Scholar 

Download references

Acknowledgements

The authors thank all patients for participating in this study. Sincere appreciations go to the THET-CYRP team, Bugando CTC, and NIMR clinic staff for their cooperation. CUHAS Physiology Department for their support, CUHAS/BMC Research Ethics and Review Committee (CREC) is thanked for approval to conduct this research and publish the findings.

Funding

This study was primarily funded by the NIH via the Transforming Health Education in Tanzania (THET) Project (grant: R25 TW011227) and partly by the EDCTP2 program supported by the European Union (grant agreement number: TMA2017GSF-1965-REEHAD). The funding agencies had no role in the study design, data collection, analysis, decision to publish results, or preparation of the manuscript. The EDCTP Association is not responsible for any use that may be made of the information contained in this publication. Dr. Bartlett receives salary support from the US National Institutes of Health P30 AI064518.

Author information

Authors and Affiliations

  1. Department of Physiology, Catholic University of Health and Allied Sciences Bugando, P.O. Box 1464, Mwanza, Tanzania

    Evangelista Malindisa & Haruna Dika

  2. Muhimbili University of Health and Allied Sciences, P.O. Box 65001, Dar Es Salaam, Tanzania

    Emmanuel Balandya, Marina Njelekela, Eligius Lyamuya & Bruno Sunguya

  3. Deloitte Consulting Limited, P.O. Box 1559, Dar Es Salaam, Tanzania

    Marina Njelekela

  4. Department of Biochemistry and Molecular Biology, Catholic University of Health and Allied Sciences Bugando, P.O. Box 1464, Mwanza, Tanzania

    Benson R. Kidenya

  5. Kilimanjaro Christian Medical University College, P.O. Box 2240, Moshi, Tanzania

    Blandina T. Mmbaga

  6. Mwanza Research Centre, National Institute for Medical Research, P.O. Box 1462, Mwanza, Tanzania

    Evangelista Malindisa & George PrayGod

  7. Duke Global Health Institute, Duke University, Durham, NC, USA

    John Bartlett

  8. Tanga Research Centre, National Institute for Medical Research, P.O. Box 5004, Tanga, Tanzania

    Filbert Francis

Authors
  1. Evangelista Malindisa
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Emmanuel Balandya
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Marina Njelekela
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Benson R. Kidenya
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Filbert Francis
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Blandina T. Mmbaga
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Haruna Dika
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Eligius Lyamuya
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Bruno Sunguya
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. John Bartlett
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. George PrayGod
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

EM conceptualized, designed the study, and collected data. EB, GP, HD, and MN supervised data collection. EM performed data analysis with help from FF and drafted the initial manuscript. All authors (i.e. EM, EB, MN, BRK, BTM, EL, BS, HD, FF, JB, and GP) interpreted data, critically reviewed the manuscript, and approved the final version for submission.

Corresponding author

Correspondence to Evangelista Malindisa.

Ethics declarations

Ethics statement

Ethical permission to conduct this study was obtained from the joint CUHAS/BMC Research Ethics and Review Committee (CREC), reference number (CREC/420/2020). Additional permission was obtained from the Bugando Medical Centre administration. The study recruited participants only after obtaining informed consent with details on the study protocol and well-explained study procedures. All methods were performed under the Declaration of Helsinki. Participants were informed of their diabetic status and nutritional status and were given health education.

Consent for publication

Not applicable.

Competing interests

The authors declare no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary Material 1

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Malindisa, E., Balandya, E., Njelekela, M. et al. Metabolic syndrome among people living with HIV on antiretroviral therapy in Mwanza, Tanzania. BMC Endocr Disord 23, 88 (2023). https://0-doi-org.brum.beds.ac.uk/10.1186/s12902-023-01340-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://0-doi-org.brum.beds.ac.uk/10.1186/s12902-023-01340-3

Keywords

BMC Endocrine Disorders

ISSN: 1472-6823

Contact us